Clinical study on VARICELLA VACCINE LIVE ATTENUATED "BIKEN" in subjects aged 50 years or older with underlying disease which influences on the immune system

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080223360

Enrollment

1500

Registered

2016-10-31

Start date

2016-11-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of herpes zoster

Interventions

investigational material(s) Generic name etc : VARICELLA VACCINE LIVE ATTENUATED "BIKEN" INN of investigational material : - Therapeutic category code : 631 Vaccines Dosage and Administration for Inve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects with underlying disease which influences on the immune system, healthy subjects

Exclusion criteria

Exclusion criteria: Individuals ineligible for vaccination (as described in the package insert) when inoculated VARICELLA VACCINE LIVE ATTENUATED "BIKEN" as prophylaxis of herpes zoster, and so on.

Design outcomes

Primary

Measure	Time frame
safety Safety	—

Secondary

Measure	Time frame
other -	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026